Cargando…

Closed reduction evaluation in dysplastic hip with the Ömeroğlu system in children aged 24 to 36 months

Closed reduction (CR) as an initial treatment for developmental hip dysplasia of the hip (DDH) in children aged 24 to 36 months is debatable; however, it could have better results than open reduction (OR) or osteotomies, because it is minimally invasive. The purpose of this study was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Charles-Lozoya, Sergio, Chávez-Valenzuela, Salvador, Cobos-Aguilar, Héctor, Manilla-Muñoz, Edgar, De La Parra-Márquez, Miguel Leonardo, Arriaga-Cazares, Héctor Eliud, García-Hernández, Adrián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981428/
https://www.ncbi.nlm.nih.gov/pubmed/36862899
http://dx.doi.org/10.1097/MD.0000000000032649
_version_ 1784900100421582848
author Charles-Lozoya, Sergio
Chávez-Valenzuela, Salvador
Cobos-Aguilar, Héctor
Manilla-Muñoz, Edgar
De La Parra-Márquez, Miguel Leonardo
Arriaga-Cazares, Héctor Eliud
García-Hernández, Adrián
author_facet Charles-Lozoya, Sergio
Chávez-Valenzuela, Salvador
Cobos-Aguilar, Héctor
Manilla-Muñoz, Edgar
De La Parra-Márquez, Miguel Leonardo
Arriaga-Cazares, Héctor Eliud
García-Hernández, Adrián
author_sort Charles-Lozoya, Sergio
collection PubMed
description Closed reduction (CR) as an initial treatment for developmental hip dysplasia of the hip (DDH) in children aged 24 to 36 months is debatable; however, it could have better results than open reduction (OR) or osteotomies, because it is minimally invasive. The purpose of this study was to evaluate the radiological results in children (24–36 months) with DDH initially treated with CR. Initial, subsequent, final anteroposterior pelvic radiological records were retrospectively analyzed. The International Hip Dysplasia Institute was used to classify the initial dislocations. To evaluate the final radiological results after CR (initial treatment) or additional treatment (CR failed), the Ömeroğlu system was used (6 points excellent, 5 good, 4 fair-plus, 3 fair-minus, and ≤2 poor). The degree of acetabular dysplasia was estimated using the initial acetabular index and the final acetabular index, Buchholz–Ogden classification was used to measure avascular necrosis (AVN). A total of 98 radiological records were eligible, including 53 patients (65 hips). Fifteen hips (23.1%) were redislocated, OR with femoral osteotomy and pelvic osteotomy was the preferred surgical treatment 9 (13.8%). The initial acetabular index versus final acetabular index in total population was (38.9º ± 6.8º) and (31.9º ± 6.8º), respectively (t = 6.5, P < .001). The prevalence of AVN was 40%. Overall AVN in OR, femoral osteotomy and pelvic osteotomy were 73.3% versus CR 30%, P = .003. Unsatisfactory results ≤ 4 points on the Ömeroğlu system were observed in hips that required OR with femoral and pelvic osteotomy. Hips with DDH treated with CR initially might had better radiological results than those treated with OR and femoral and pelvic osteotomies. Regular, good, and excellent results, ≥4 points on the Ömeroğlu system, could be estimated in 57% of the cases, in whom CR was successful. AVN is frequently observed in hips with failed CR.
format Online
Article
Text
id pubmed-9981428
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-99814282023-03-04 Closed reduction evaluation in dysplastic hip with the Ömeroğlu system in children aged 24 to 36 months Charles-Lozoya, Sergio Chávez-Valenzuela, Salvador Cobos-Aguilar, Héctor Manilla-Muñoz, Edgar De La Parra-Márquez, Miguel Leonardo Arriaga-Cazares, Héctor Eliud García-Hernández, Adrián Medicine (Baltimore) 7100 Closed reduction (CR) as an initial treatment for developmental hip dysplasia of the hip (DDH) in children aged 24 to 36 months is debatable; however, it could have better results than open reduction (OR) or osteotomies, because it is minimally invasive. The purpose of this study was to evaluate the radiological results in children (24–36 months) with DDH initially treated with CR. Initial, subsequent, final anteroposterior pelvic radiological records were retrospectively analyzed. The International Hip Dysplasia Institute was used to classify the initial dislocations. To evaluate the final radiological results after CR (initial treatment) or additional treatment (CR failed), the Ömeroğlu system was used (6 points excellent, 5 good, 4 fair-plus, 3 fair-minus, and ≤2 poor). The degree of acetabular dysplasia was estimated using the initial acetabular index and the final acetabular index, Buchholz–Ogden classification was used to measure avascular necrosis (AVN). A total of 98 radiological records were eligible, including 53 patients (65 hips). Fifteen hips (23.1%) were redislocated, OR with femoral osteotomy and pelvic osteotomy was the preferred surgical treatment 9 (13.8%). The initial acetabular index versus final acetabular index in total population was (38.9º ± 6.8º) and (31.9º ± 6.8º), respectively (t = 6.5, P < .001). The prevalence of AVN was 40%. Overall AVN in OR, femoral osteotomy and pelvic osteotomy were 73.3% versus CR 30%, P = .003. Unsatisfactory results ≤ 4 points on the Ömeroğlu system were observed in hips that required OR with femoral and pelvic osteotomy. Hips with DDH treated with CR initially might had better radiological results than those treated with OR and femoral and pelvic osteotomies. Regular, good, and excellent results, ≥4 points on the Ömeroğlu system, could be estimated in 57% of the cases, in whom CR was successful. AVN is frequently observed in hips with failed CR. Lippincott Williams & Wilkins 2023-03-03 /pmc/articles/PMC9981428/ /pubmed/36862899 http://dx.doi.org/10.1097/MD.0000000000032649 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 7100
Charles-Lozoya, Sergio
Chávez-Valenzuela, Salvador
Cobos-Aguilar, Héctor
Manilla-Muñoz, Edgar
De La Parra-Márquez, Miguel Leonardo
Arriaga-Cazares, Héctor Eliud
García-Hernández, Adrián
Closed reduction evaluation in dysplastic hip with the Ömeroğlu system in children aged 24 to 36 months
title Closed reduction evaluation in dysplastic hip with the Ömeroğlu system in children aged 24 to 36 months
title_full Closed reduction evaluation in dysplastic hip with the Ömeroğlu system in children aged 24 to 36 months
title_fullStr Closed reduction evaluation in dysplastic hip with the Ömeroğlu system in children aged 24 to 36 months
title_full_unstemmed Closed reduction evaluation in dysplastic hip with the Ömeroğlu system in children aged 24 to 36 months
title_short Closed reduction evaluation in dysplastic hip with the Ömeroğlu system in children aged 24 to 36 months
title_sort closed reduction evaluation in dysplastic hip with the ömeroğlu system in children aged 24 to 36 months
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981428/
https://www.ncbi.nlm.nih.gov/pubmed/36862899
http://dx.doi.org/10.1097/MD.0000000000032649
work_keys_str_mv AT charleslozoyasergio closedreductionevaluationindysplastichipwiththeomeroglusysteminchildrenaged24to36months
AT chavezvalenzuelasalvador closedreductionevaluationindysplastichipwiththeomeroglusysteminchildrenaged24to36months
AT cobosaguilarhector closedreductionevaluationindysplastichipwiththeomeroglusysteminchildrenaged24to36months
AT manillamunozedgar closedreductionevaluationindysplastichipwiththeomeroglusysteminchildrenaged24to36months
AT delaparramarquezmiguelleonardo closedreductionevaluationindysplastichipwiththeomeroglusysteminchildrenaged24to36months
AT arriagacazareshectoreliud closedreductionevaluationindysplastichipwiththeomeroglusysteminchildrenaged24to36months
AT garciahernandezadrian closedreductionevaluationindysplastichipwiththeomeroglusysteminchildrenaged24to36months